Product Images Romvimza
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Romvimza NDC 73207-303 by Deciphera Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - rom04 0001 01
Figure 1 - rom04 0001 02
Principal Display Panel – 14 mg Carton Label - rom04 0001 03
Each capsule contains 14 mg of vimseltinib. The recommended dosage is provided in the prescribing information. Swallow the capsules whole and do not open, break, or chew them. This package is child-resistant and should be kept out of reach of children. The capsules should be stored at 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication is manufactured for and marketed by Deciphera Pharmaceuticals in Waltham, MA. For more information, visit the website or call the provided number. The capsules are a 4-week supply containing 8 capsules per blister pack.*
Principal Display Panel – 20 mg Carton Label - rom04 0001 04
This text provides information about a medication called Romvimza, which contains vimseltinib. Each capsule contains 20 mg of vimseltinib. The recommended dosage is not provided and refers to the prescribing information for details. It is important to swallow the capsules whole and not open, break, or chew them. The medication should be kept out of reach of children as the packaging is child-resistant. It should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The manufacturing and marketing are handled by Deciphera Pharmaceuticals, LLC based in Waltham, MA. Contact details for further information or inquiries are available at www.romvimza.com or by calling 1-888-724-8274.*
Principal Display Panel – 30 mg Carton Label - rom04 0001 05
Each capsule of Romvimza contains 30 mg of vimseltinib. The recommended dosage is specified in the prescribing information. The capsules should be swallowed whole and should not be opened, broken, or chewed. The package is child-resistant to ensure safety. Store between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). Romvimza is manufactured for and marketed by Deciphera Pharmaceuticals in Waltham, MA. For more information, visit www.romvimza.com or call 1-888-724-8274.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
